Latest News

  • CAR T cells generated in vivo

    Following earlier approvals in the US, two CAR-T cell therapeutics obtained marketing authorization from the European Commission in August 2018. The new CAR-T cell therapies provide treatment options for cancer patients who have failed to responded to other treatment options. Immune cells are extracted from the patient, genetically modified to...
  • CAR T cells in cancer treatment: make T cells great again!

    9th Institut Cochin Symposium in Paris, France organised by CARAT partner INSERM
  • CARAT contributing to advance automatic therapeutic cell production

    Horizon - The EU Research & Innovation Magazine has published an article on the advances of cell production factories in bringing life-saving cell therapies to an ever larger number of patients. The CARAT project is featured in this article as the project is contributing to improve Miltenyi’s CliniMACS Prodigy – a machine built for automatic...
  • Reaching out to the scientific community: Successful CARAT meeting and workshop in Freiburg

    On June 25-27, 2018, the CARAT consortium met for their extended 3rd Progress Meeting kindly hosted by Prof. Toni Cathomen and his team from the University Medical Center in Freiburg. 2.5 years into the project, the agenda was packed not only with internal monitoring and planning activities but also with exciting external undertakings in terms of...
  • CARAT at EBMT in Lisbon

    During the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Lisbon, Portugal, CARAT was very active in further promoting CAR T cells for cellular therapy. A central event was the very successful joint EBMT-CARAT session on March 19, 2018 chaired by Christian Chabannon (Aix-Marseille University School of...
  • Cell Therapy – Challenges & Success Stories

    CARAT approach mentioned as solution for challenges in GoingPublic Magazin
  • CAR T-Cell Immunotherapy Named Advance of the Year in Annual ASCO Report

    A new and unique new way to treat cancer – CAR T-cell therapy – is poised to transform the outlook for children and adults with certain otherwise incurable cancers. The American Society of Clinical Oncology (ASCO) named this type of adoptive cell immunotherapy the Advance of the Year in its annual report. Released within the scope of the World...
  • CARAT Training Fellowship

    GMP-compliant CAR T Cell Manufacturing Training Course December 10-14, 2018

Upcoming Events